| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chlamydia Infections | 45 | 2025 | 200 | 10.910 |
Why?
|
| Chlamydia muridarum | 31 | 2023 | 104 | 7.680 |
Why?
|
| Bacterial Vaccines | 28 | 2017 | 129 | 6.610 |
Why?
|
| Francisella tularensis | 26 | 2017 | 116 | 5.940 |
Why?
|
| Tularemia | 26 | 2018 | 115 | 5.670 |
Why?
|
| Acinetobacter baumannii | 8 | 2025 | 40 | 3.880 |
Why?
|
| Interferon-gamma | 33 | 2021 | 269 | 3.530 |
Why?
|
| Mast Cells | 8 | 2016 | 82 | 2.940 |
Why?
|
| Thioredoxins | 5 | 2025 | 41 | 2.580 |
Why?
|
| Endopeptidases | 11 | 2018 | 64 | 2.580 |
Why?
|
| Mice | 82 | 2025 | 6644 | 2.500 |
Why?
|
| Antibodies, Bacterial | 19 | 2017 | 117 | 2.490 |
Why?
|
| Genital Diseases, Female | 8 | 2013 | 38 | 2.380 |
Why?
|
| Lung | 15 | 2021 | 492 | 2.170 |
Why?
|
| Macrophages | 16 | 2023 | 529 | 2.140 |
Why?
|
| Mice, Inbred C57BL | 43 | 2023 | 1869 | 2.130 |
Why?
|
| MicroRNAs | 6 | 2021 | 518 | 2.100 |
Why?
|
| Animals | 104 | 2025 | 16992 | 2.050 |
Why?
|
| Chlamydia trachomatis | 12 | 2025 | 70 | 2.000 |
Why?
|
| CD4-Positive T-Lymphocytes | 10 | 2019 | 279 | 1.830 |
Why?
|
| Mice, Inbred BALB C | 34 | 2019 | 694 | 1.820 |
Why?
|
| Interleukin-12 | 15 | 2016 | 46 | 1.820 |
Why?
|
| Virulence Factors | 8 | 2025 | 125 | 1.760 |
Why?
|
| Bacterial Proteins | 15 | 2019 | 595 | 1.740 |
Why?
|
| Antigens, Bacterial | 9 | 2014 | 144 | 1.710 |
Why?
|
| Genitalia, Female | 6 | 2021 | 29 | 1.670 |
Why?
|
| Acinetobacter Infections | 5 | 2025 | 29 | 1.460 |
Why?
|
| Vaccines, Attenuated | 9 | 2017 | 75 | 1.420 |
Why?
|
| Adjuvants, Immunologic | 13 | 2011 | 117 | 1.420 |
Why?
|
| Administration, Intranasal | 19 | 2014 | 89 | 1.300 |
Why?
|
| Immunoglobulin A | 7 | 2022 | 65 | 1.300 |
Why?
|
| Interleukin-4 | 6 | 2018 | 75 | 1.240 |
Why?
|
| Bacterial Outer Membrane Proteins | 4 | 2021 | 57 | 1.240 |
Why?
|
| Host-Pathogen Interactions | 11 | 2025 | 209 | 1.190 |
Why?
|
| Sepsis | 5 | 2019 | 90 | 1.140 |
Why?
|
| Vaccination | 11 | 2017 | 355 | 1.090 |
Why?
|
| Mice, Knockout | 20 | 2016 | 1035 | 1.050 |
Why?
|
| Gastrointestinal Tract | 5 | 2021 | 71 | 1.040 |
Why?
|
| Immunoglobulin A, Secretory | 3 | 2018 | 16 | 0.980 |
Why?
|
| C-Reactive Protein | 3 | 2017 | 167 | 0.970 |
Why?
|
| Immunization | 7 | 2016 | 94 | 0.960 |
Why?
|
| Francisella | 3 | 2012 | 20 | 0.960 |
Why?
|
| Phagosomes | 3 | 2018 | 33 | 0.960 |
Why?
|
| Receptors, IgE | 3 | 2016 | 22 | 0.940 |
Why?
|
| Bacterial Infections | 2 | 2018 | 45 | 0.920 |
Why?
|
| Whole Body Imaging | 2 | 2014 | 25 | 0.870 |
Why?
|
| Spleen | 13 | 2017 | 204 | 0.870 |
Why?
|
| Female | 55 | 2025 | 24698 | 0.850 |
Why?
|
| Fimbriae, Bacterial | 2 | 2025 | 30 | 0.830 |
Why?
|
| Fallopian Tubes | 4 | 2013 | 19 | 0.800 |
Why?
|
| HLA-DR4 Antigen | 3 | 2013 | 21 | 0.780 |
Why?
|
| Pneumonia, Bacterial | 4 | 2013 | 24 | 0.780 |
Why?
|
| Genitalia | 3 | 2018 | 18 | 0.780 |
Why?
|
| Hela Cells | 16 | 2025 | 376 | 0.770 |
Why?
|
| Animals, Newborn | 7 | 2016 | 352 | 0.760 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2013 | 384 | 0.750 |
Why?
|
| Cross Infection | 1 | 2022 | 48 | 0.740 |
Why?
|
| Cells, Cultured | 16 | 2018 | 1621 | 0.740 |
Why?
|
| Immunity, Humoral | 1 | 2022 | 29 | 0.720 |
Why?
|
| Immunity, Innate | 8 | 2021 | 171 | 0.720 |
Why?
|
| Th1 Cells | 9 | 2019 | 97 | 0.700 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2013 | 60 | 0.670 |
Why?
|
| Humans | 51 | 2025 | 43102 | 0.670 |
Why?
|
| Immunologic Factors | 2 | 2018 | 51 | 0.660 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2021 | 184 | 0.630 |
Why?
|
| Serum Amyloid P-Component | 2 | 2017 | 21 | 0.620 |
Why?
|
| Caspase 1 | 2 | 2016 | 16 | 0.620 |
Why?
|
| Oligodeoxyribonucleotides | 5 | 2016 | 50 | 0.610 |
Why?
|
| Gene Deletion | 4 | 2018 | 168 | 0.600 |
Why?
|
| Chlamydia | 4 | 2021 | 45 | 0.580 |
Why?
|
| Bacterial Adhesion | 2 | 2018 | 41 | 0.570 |
Why?
|
| Intestines | 3 | 2016 | 71 | 0.570 |
Why?
|
| Rats, Inbred F344 | 5 | 2017 | 258 | 0.560 |
Why?
|
| Chlamydophila pneumoniae | 2 | 2015 | 7 | 0.560 |
Why?
|
| Respiratory Tract Infections | 2 | 2016 | 36 | 0.540 |
Why?
|
| Gram-Negative Bacteria | 1 | 2017 | 29 | 0.530 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2017 | 28 | 0.530 |
Why?
|
| Disease Models, Animal | 10 | 2025 | 1596 | 0.510 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2016 | 12 | 0.500 |
Why?
|
| Gene Expression Regulation | 10 | 2020 | 1070 | 0.500 |
Why?
|
| Coculture Techniques | 5 | 2016 | 109 | 0.500 |
Why?
|
| Bone Marrow Cells | 3 | 2012 | 79 | 0.500 |
Why?
|
| Orthomyxoviridae Infections | 3 | 2001 | 14 | 0.490 |
Why?
|
| Immunity | 4 | 2021 | 61 | 0.480 |
Why?
|
| Up-Regulation | 2 | 2016 | 536 | 0.480 |
Why?
|
| Cervix Uteri | 3 | 2025 | 48 | 0.480 |
Why?
|
| Immunoglobulin G | 10 | 2022 | 259 | 0.470 |
Why?
|
| Granzymes | 2 | 2013 | 19 | 0.470 |
Why?
|
| Perforin | 2 | 2012 | 11 | 0.460 |
Why?
|
| Influenza Vaccines | 3 | 2001 | 58 | 0.460 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2015 | 59 | 0.450 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 28 | 0.450 |
Why?
|
| Colony Count, Microbial | 6 | 2020 | 67 | 0.440 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2014 | 6 | 0.440 |
Why?
|
| Immunity, Mucosal | 4 | 2017 | 53 | 0.440 |
Why?
|
| Vagina | 7 | 2013 | 89 | 0.430 |
Why?
|
| Flagellin | 1 | 2014 | 19 | 0.430 |
Why?
|
| Shock, Septic | 1 | 2014 | 20 | 0.430 |
Why?
|
| Recombinant Proteins | 5 | 2021 | 518 | 0.420 |
Why?
|
| Survival Analysis | 6 | 2018 | 368 | 0.410 |
Why?
|
| Gene Expression Profiling | 3 | 2025 | 704 | 0.400 |
Why?
|
| Plasmids | 4 | 2020 | 244 | 0.400 |
Why?
|
| Virulence | 9 | 2025 | 246 | 0.400 |
Why?
|
| Down-Regulation | 1 | 2015 | 456 | 0.400 |
Why?
|
| Adenosine Triphosphate | 2 | 2012 | 206 | 0.400 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2013 | 11 | 0.390 |
Why?
|
| Signal Transduction | 7 | 2025 | 2157 | 0.390 |
Why?
|
| Cystatins | 3 | 2019 | 19 | 0.390 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2013 | 18 | 0.390 |
Why?
|
| Genomic Islands | 2 | 2009 | 16 | 0.390 |
Why?
|
| Alkaline Phosphatase | 1 | 2012 | 54 | 0.380 |
Why?
|
| Anti-Bacterial Agents | 6 | 2018 | 432 | 0.370 |
Why?
|
| Bacteremia | 1 | 2012 | 37 | 0.370 |
Why?
|
| Mucous Membrane | 1 | 2012 | 34 | 0.370 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2012 | 57 | 0.370 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 28 | 0.370 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2011 | 7 | 0.370 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 386 | 0.360 |
Why?
|
| Antibodies, Viral | 4 | 2022 | 306 | 0.350 |
Why?
|
| Adoptive Transfer | 6 | 2021 | 53 | 0.350 |
Why?
|
| Respiratory System | 1 | 2011 | 31 | 0.350 |
Why?
|
| Influenza A virus | 4 | 2009 | 31 | 0.350 |
Why?
|
| Mannose | 1 | 2011 | 32 | 0.340 |
Why?
|
| Oligosaccharides | 1 | 2011 | 29 | 0.340 |
Why?
|
| Infertility, Female | 1 | 2011 | 24 | 0.340 |
Why?
|
| Vibrio cholerae | 2 | 2011 | 105 | 0.340 |
Why?
|
| Guinea Pigs | 3 | 2016 | 143 | 0.330 |
Why?
|
| Immunization, Passive | 3 | 2022 | 19 | 0.330 |
Why?
|
| Sexually Transmitted Diseases, Bacterial | 1 | 2009 | 7 | 0.310 |
Why?
|
| Intestinal Mucosa | 2 | 2011 | 134 | 0.310 |
Why?
|
| Cytokines | 9 | 2018 | 678 | 0.310 |
Why?
|
| Interleukin-17 | 3 | 2016 | 53 | 0.310 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 101 | 0.310 |
Why?
|
| T-Lymphocytes | 3 | 2009 | 386 | 0.300 |
Why?
|
| Lymphocytes | 3 | 2021 | 124 | 0.300 |
Why?
|
| Biofilms | 1 | 2011 | 184 | 0.290 |
Why?
|
| Neutrophils | 3 | 2015 | 145 | 0.290 |
Why?
|
| Contact Inhibition | 1 | 2008 | 4 | 0.290 |
Why?
|
| Vaginal Diseases | 1 | 2008 | 9 | 0.280 |
Why?
|
| Antibodies, Neutralizing | 2 | 2022 | 127 | 0.280 |
Why?
|
| Colon | 2 | 2021 | 120 | 0.270 |
Why?
|
| DNA Replication | 1 | 2008 | 148 | 0.270 |
Why?
|
| Chemokines | 2 | 2021 | 96 | 0.270 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2018 | 247 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 760 | 0.250 |
Why?
|
| Receptors, Polymeric Immunoglobulin | 1 | 2006 | 2 | 0.250 |
Why?
|
| IgA Deficiency | 2 | 2009 | 6 | 0.250 |
Why?
|
| Lymphocyte Activation | 4 | 2016 | 249 | 0.250 |
Why?
|
| Antibodies, Monoclonal | 2 | 2022 | 306 | 0.240 |
Why?
|
| Chaperonin 60 | 2 | 2018 | 15 | 0.240 |
Why?
|
| Antigens, Surface | 3 | 2001 | 52 | 0.240 |
Why?
|
| Fimbriae Proteins | 1 | 2025 | 25 | 0.240 |
Why?
|
| Aging | 1 | 2011 | 783 | 0.240 |
Why?
|
| Osteoblasts | 4 | 2012 | 44 | 0.240 |
Why?
|
| Colitis | 1 | 2006 | 71 | 0.230 |
Why?
|
| Administration, Oral | 3 | 2012 | 260 | 0.230 |
Why?
|
| Cell Line | 4 | 2014 | 1410 | 0.230 |
Why?
|
| Vaccines, Synthetic | 3 | 2010 | 80 | 0.230 |
Why?
|
| Inflammation | 4 | 2023 | 758 | 0.230 |
Why?
|
| Microscopy, Confocal | 2 | 2016 | 224 | 0.230 |
Why?
|
| Models, Animal | 4 | 2017 | 151 | 0.230 |
Why?
|
| Epithelial Cells | 2 | 2025 | 434 | 0.220 |
Why?
|
| Phagocytosis | 5 | 2013 | 86 | 0.220 |
Why?
|
| Mice, Transgenic | 4 | 2013 | 665 | 0.210 |
Why?
|
| Immunity, Cellular | 2 | 2008 | 74 | 0.210 |
Why?
|
| Antibody Formation | 4 | 2013 | 76 | 0.210 |
Why?
|
| Cell Communication | 2 | 2016 | 114 | 0.210 |
Why?
|
| Protein Transport | 2 | 2016 | 296 | 0.200 |
Why?
|
| Species Specificity | 2 | 2014 | 286 | 0.190 |
Why?
|
| Antigen Presentation | 2 | 2016 | 58 | 0.190 |
Why?
|
| Bacteria | 2 | 2019 | 293 | 0.190 |
Why?
|
| Acid Phosphatase | 2 | 2021 | 23 | 0.190 |
Why?
|
| Caspase 3 | 2 | 2015 | 227 | 0.180 |
Why?
|
| Carcinoma | 1 | 2023 | 108 | 0.180 |
Why?
|
| Income | 1 | 2023 | 160 | 0.180 |
Why?
|
| Mutagenesis, Insertional | 3 | 2025 | 39 | 0.180 |
Why?
|
| Cystatin C | 2 | 2019 | 25 | 0.180 |
Why?
|
| Pneumococcal Infections | 1 | 2001 | 33 | 0.180 |
Why?
|
| Immunoglobulin M | 3 | 2017 | 86 | 0.180 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 224 | 0.180 |
Why?
|
| Klebsiella pneumoniae | 2 | 2019 | 26 | 0.170 |
Why?
|
| Immunomodulation | 2 | 2019 | 17 | 0.170 |
Why?
|
| Immunity, Active | 2 | 2013 | 6 | 0.170 |
Why?
|
| Pertussis Toxin | 2 | 2011 | 25 | 0.170 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2001 | 47 | 0.160 |
Why?
|
| Genes, MHC Class I | 2 | 2012 | 15 | 0.160 |
Why?
|
| Genes, MHC Class II | 2 | 2012 | 21 | 0.160 |
Why?
|
| Monocytes | 2 | 2014 | 277 | 0.160 |
Why?
|
| Cell Death | 2 | 2012 | 278 | 0.160 |
Why?
|
| Intestine, Small | 2 | 2019 | 25 | 0.160 |
Why?
|
| Oviducts | 3 | 2013 | 13 | 0.160 |
Why?
|
| Proteome | 1 | 2021 | 152 | 0.160 |
Why?
|
| Osteogenesis | 3 | 2012 | 57 | 0.160 |
Why?
|
| beta-Lactamases | 2 | 2018 | 34 | 0.150 |
Why?
|
| Infertility | 1 | 2019 | 21 | 0.150 |
Why?
|
| Intestine, Large | 1 | 2019 | 5 | 0.150 |
Why?
|
| Refrigeration | 1 | 2019 | 4 | 0.150 |
Why?
|
| Blood Preservation | 1 | 2019 | 6 | 0.150 |
Why?
|
| Disinfection | 1 | 2019 | 10 | 0.150 |
Why?
|
| Rats | 7 | 2017 | 3735 | 0.150 |
Why?
|
| Nasal Mucosa | 1 | 1999 | 35 | 0.150 |
Why?
|
| Lymphocyte Depletion | 2 | 2009 | 14 | 0.150 |
Why?
|
| B-Lymphocytes | 2 | 2016 | 189 | 0.140 |
Why?
|
| Blood Platelets | 1 | 2019 | 81 | 0.140 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 3 | 2011 | 15 | 0.140 |
Why?
|
| Host-Parasite Interactions | 2 | 2017 | 79 | 0.140 |
Why?
|
| Mycobacterium bovis | 1 | 2018 | 14 | 0.140 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2021 | 388 | 0.140 |
Why?
|
| Immune Evasion | 1 | 2018 | 17 | 0.140 |
Why?
|
| Genome, Bacterial | 2 | 2020 | 139 | 0.140 |
Why?
|
| Mycobacterium Infections | 1 | 2018 | 16 | 0.140 |
Why?
|
| Klebsiella Infections | 1 | 2018 | 11 | 0.140 |
Why?
|
| Endosomes | 1 | 2018 | 33 | 0.140 |
Why?
|
| Electric Stimulation | 2 | 2012 | 186 | 0.140 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2019 | 171 | 0.140 |
Why?
|
| Molecular Weight | 2 | 2021 | 168 | 0.140 |
Why?
|
| Cell Polarity | 1 | 2018 | 57 | 0.130 |
Why?
|
| Intubation, Intratracheal | 1 | 2017 | 23 | 0.130 |
Why?
|
| Tissue Engineering | 2 | 2012 | 75 | 0.130 |
Why?
|
| Neutrophil Infiltration | 2 | 2015 | 28 | 0.130 |
Why?
|
| Urogenital System | 1 | 2017 | 2 | 0.130 |
Why?
|
| Adaptive Immunity | 1 | 2017 | 34 | 0.130 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2017 | 19 | 0.130 |
Why?
|
| Vaccines, Subunit | 2 | 2007 | 34 | 0.130 |
Why?
|
| Disease Progression | 1 | 2020 | 667 | 0.130 |
Why?
|
| Influenza B virus | 2 | 2007 | 5 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2001 | 734 | 0.130 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 457 | 0.130 |
Why?
|
| Transfection | 1 | 2018 | 532 | 0.130 |
Why?
|
| Cell Surface Extensions | 1 | 2016 | 9 | 0.130 |
Why?
|
| Cell Differentiation | 2 | 2017 | 638 | 0.120 |
Why?
|
| Mutation | 4 | 2025 | 1177 | 0.120 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2016 | 18 | 0.120 |
Why?
|
| DNA, Bacterial | 3 | 2019 | 206 | 0.120 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2016 | 5 | 0.120 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2016 | 15 | 0.120 |
Why?
|
| Respiratory Function Tests | 1 | 2016 | 61 | 0.120 |
Why?
|
| Interleukin-2 | 1 | 2016 | 91 | 0.120 |
Why?
|
| Immunologic Memory | 3 | 2001 | 42 | 0.120 |
Why?
|
| Genes, Bacterial | 3 | 2011 | 91 | 0.110 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2015 | 24 | 0.110 |
Why?
|
| Mice, Obese | 1 | 2015 | 42 | 0.110 |
Why?
|
| Receptors, IgG | 2 | 2008 | 53 | 0.110 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2015 | 159 | 0.110 |
Why?
|
| Nitric Oxide | 1 | 2018 | 386 | 0.110 |
Why?
|
| Immunodominant Epitopes | 1 | 2014 | 29 | 0.110 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 75 | 0.110 |
Why?
|
| RNA, Messenger | 5 | 2004 | 1271 | 0.110 |
Why?
|
| Body Fluids | 1 | 2014 | 19 | 0.110 |
Why?
|
| Obesity | 1 | 2023 | 1151 | 0.110 |
Why?
|
| Macrophages, Alveolar | 2 | 2013 | 34 | 0.110 |
Why?
|
| Molecular Imaging | 1 | 2014 | 30 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 436 | 0.110 |
Why?
|
| Fluorescence | 1 | 2014 | 118 | 0.110 |
Why?
|
| Cross Reactions | 3 | 2013 | 87 | 0.110 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2012 | 63 | 0.110 |
Why?
|
| Peroxidase | 1 | 2014 | 57 | 0.110 |
Why?
|
| Fallopian Tube Diseases | 1 | 2013 | 1 | 0.100 |
Why?
|
| Drug Therapy, Combination | 2 | 2007 | 234 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2015 | 411 | 0.100 |
Why?
|
| Chickens | 2 | 2009 | 161 | 0.100 |
Why?
|
| Bacterial Shedding | 1 | 2013 | 3 | 0.100 |
Why?
|
| Cell Degranulation | 1 | 2013 | 10 | 0.100 |
Why?
|
| Ligands | 1 | 2014 | 388 | 0.100 |
Why?
|
| Mice, SCID | 2 | 2011 | 158 | 0.100 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 2012 | 7 | 0.100 |
Why?
|
| Microbial Viability | 2 | 2009 | 42 | 0.100 |
Why?
|
| Receptors, Cell Surface | 2 | 2010 | 146 | 0.100 |
Why?
|
| Adult | 4 | 2023 | 13872 | 0.090 |
Why?
|
| Norepinephrine | 3 | 1997 | 97 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2012 | 14 | 0.090 |
Why?
|
| Killer Cells, Natural | 2 | 2007 | 104 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 2 | 2004 | 216 | 0.090 |
Why?
|
| Major Histocompatibility Complex | 1 | 2012 | 29 | 0.090 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2012 | 72 | 0.090 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2012 | 54 | 0.090 |
Why?
|
| Proteinase Inhibitory Proteins, Secretory | 1 | 2011 | 3 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 652 | 0.090 |
Why?
|
| Haptoglobins | 1 | 2011 | 10 | 0.090 |
Why?
|
| Leukocyte Elastase | 1 | 2011 | 12 | 0.090 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2003 | 61 | 0.090 |
Why?
|
| Mice, Inbred CBA | 3 | 2021 | 42 | 0.090 |
Why?
|
| Time Factors | 4 | 2019 | 1857 | 0.090 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 140 | 0.090 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 65 | 0.090 |
Why?
|
| Liver | 1 | 2015 | 511 | 0.090 |
Why?
|
| Lung Compliance | 1 | 2011 | 3 | 0.090 |
Why?
|
| Erythromycin | 1 | 2011 | 14 | 0.090 |
Why?
|
| Cell Survival | 1 | 2015 | 945 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2010 | 296 | 0.090 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2011 | 12 | 0.090 |
Why?
|
| Asthma | 1 | 2016 | 416 | 0.090 |
Why?
|
| Pulmonary Alveoli | 1 | 2011 | 28 | 0.090 |
Why?
|
| Cloaca | 1 | 2011 | 4 | 0.090 |
Why?
|
| Orthomyxoviridae | 1 | 2011 | 5 | 0.090 |
Why?
|
| Polymyxin B | 1 | 2011 | 8 | 0.090 |
Why?
|
| Genetic Complementation Test | 1 | 2011 | 56 | 0.090 |
Why?
|
| Integrin alpha4beta1 | 1 | 2011 | 5 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2011 | 153 | 0.090 |
Why?
|
| Nitrites | 1 | 2011 | 55 | 0.090 |
Why?
|
| Pregnancy | 3 | 2023 | 1772 | 0.090 |
Why?
|
| Anaphylaxis | 1 | 2011 | 15 | 0.080 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2010 | 10 | 0.080 |
Why?
|
| Mannose-Binding Lectins | 1 | 2010 | 14 | 0.080 |
Why?
|
| Ducks | 1 | 2011 | 30 | 0.080 |
Why?
|
| Organelles | 1 | 2010 | 20 | 0.080 |
Why?
|
| Tryptophan | 1 | 2011 | 66 | 0.080 |
Why?
|
| Milk | 1 | 2011 | 56 | 0.080 |
Why?
|
| Survival Rate | 2 | 2009 | 355 | 0.080 |
Why?
|
| Lectins, C-Type | 1 | 2010 | 37 | 0.080 |
Why?
|
| Receptors, Interferon | 1 | 2010 | 14 | 0.080 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 55 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2012 | 307 | 0.080 |
Why?
|
| Interleukin-10 | 2 | 2001 | 87 | 0.080 |
Why?
|
| Cell Movement | 2 | 2013 | 655 | 0.080 |
Why?
|
| Aged | 1 | 2023 | 8214 | 0.080 |
Why?
|
| Lymphogranuloma Venereum | 1 | 2010 | 5 | 0.080 |
Why?
|
| Vaccines, Inactivated | 1 | 2010 | 18 | 0.080 |
Why?
|
| Protein Denaturation | 1 | 2010 | 41 | 0.080 |
Why?
|
| Cricetinae | 1 | 2010 | 241 | 0.080 |
Why?
|
| Oligopeptides | 1 | 2010 | 109 | 0.080 |
Why?
|
| Influenza in Birds | 1 | 2009 | 11 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2010 | 462 | 0.080 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2009 | 16 | 0.080 |
Why?
|
| Phenotype | 1 | 2012 | 780 | 0.080 |
Why?
|
| Membrane Transport Proteins | 1 | 2009 | 100 | 0.070 |
Why?
|
| Hot Temperature | 1 | 2010 | 141 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 458 | 0.070 |
Why?
|
| Gene Expression | 3 | 2002 | 701 | 0.070 |
Why?
|
| Protein Binding | 1 | 2012 | 1082 | 0.070 |
Why?
|
| Influenza, Human | 2 | 2007 | 92 | 0.070 |
Why?
|
| DNA Transposable Elements | 2 | 2025 | 55 | 0.070 |
Why?
|
| Intracellular Space | 1 | 2008 | 37 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 458 | 0.070 |
Why?
|
| beta 2-Microglobulin | 1 | 2008 | 10 | 0.070 |
Why?
|
| Malaysia | 2 | 2019 | 10 | 0.070 |
Why?
|
| Bacterial Toxins | 3 | 1997 | 50 | 0.070 |
Why?
|
| Gene Targeting | 1 | 2008 | 39 | 0.070 |
Why?
|
| Alleles | 2 | 2006 | 352 | 0.070 |
Why?
|
| Introns | 1 | 2008 | 79 | 0.070 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2019 | 245 | 0.070 |
Why?
|
| Computational Biology | 1 | 2009 | 327 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2008 | 238 | 0.070 |
Why?
|
| Interleukin-15 | 1 | 2007 | 13 | 0.060 |
Why?
|
| Immunotherapy | 2 | 2019 | 144 | 0.060 |
Why?
|
| Epitopes | 1 | 2007 | 157 | 0.060 |
Why?
|
| Body Weight | 1 | 2009 | 429 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2006 | 55 | 0.060 |
Why?
|
| CpG Islands | 1 | 2007 | 109 | 0.060 |
Why?
|
| Female Urogenital Diseases | 1 | 2006 | 3 | 0.060 |
Why?
|
| Escherichia coli O157 | 2 | 1997 | 17 | 0.060 |
Why?
|
| Dextran Sulfate | 1 | 2006 | 19 | 0.060 |
Why?
|
| Inclusion Bodies | 1 | 2006 | 34 | 0.060 |
Why?
|
| Occult Blood | 1 | 2006 | 32 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2007 | 206 | 0.060 |
Why?
|
| Citric Acid Cycle | 1 | 2025 | 7 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 196 | 0.060 |
Why?
|
| Biosensing Techniques | 1 | 2008 | 136 | 0.060 |
Why?
|
| Gentamicins | 1 | 2004 | 10 | 0.060 |
Why?
|
| Base Sequence | 3 | 2007 | 983 | 0.060 |
Why?
|
| Amoeba | 1 | 2004 | 6 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2005 | 116 | 0.050 |
Why?
|
| Streptococcus pneumoniae | 2 | 2001 | 34 | 0.050 |
Why?
|
| DNA Repair | 1 | 2025 | 198 | 0.050 |
Why?
|
| Pneumococcal Vaccines | 2 | 2001 | 16 | 0.050 |
Why?
|
| Escherichia coli | 2 | 1997 | 460 | 0.050 |
Why?
|
| Osteocalcin | 1 | 2003 | 5 | 0.050 |
Why?
|
| Physical Stimulation | 1 | 2003 | 27 | 0.050 |
Why?
|
| Calcium | 2 | 2003 | 491 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2019 | 1759 | 0.050 |
Why?
|
| Collagen | 1 | 2003 | 181 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 3 | 2011 | 515 | 0.050 |
Why?
|
| Bone Resorption | 1 | 2002 | 22 | 0.050 |
Why?
|
| Dinitrophenols | 2 | 1999 | 6 | 0.050 |
Why?
|
| Osteoclasts | 1 | 2002 | 28 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 455 | 0.050 |
Why?
|
| Composite Resins | 1 | 2002 | 5 | 0.050 |
Why?
|
| Ovalbumin | 2 | 1999 | 47 | 0.050 |
Why?
|
| Electric Conductivity | 1 | 2002 | 55 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 2676 | 0.050 |
Why?
|
| DNA Primers | 2 | 2001 | 294 | 0.050 |
Why?
|
| Mitochondria | 1 | 2025 | 523 | 0.040 |
Why?
|
| Proteomics | 2 | 2016 | 378 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2011 | 1542 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2021 | 35 | 0.040 |
Why?
|
| Glutathione Transferase | 2 | 2016 | 90 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2021 | 97 | 0.040 |
Why?
|
| Lymphocyte Transfusion | 1 | 2021 | 2 | 0.040 |
Why?
|
| Meningococcal Vaccines | 1 | 2001 | 6 | 0.040 |
Why?
|
| HN Protein | 1 | 2001 | 1 | 0.040 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2001 | 12 | 0.040 |
Why?
|
| HIV-1 | 1 | 2007 | 755 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2021 | 219 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2006 | 1455 | 0.040 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2000 | 16 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2000 | 60 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2000 | 62 | 0.040 |
Why?
|
| Bacteria, Anaerobic | 1 | 2019 | 10 | 0.040 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2019 | 14 | 0.040 |
Why?
|
| Neuraminidase | 1 | 1999 | 9 | 0.040 |
Why?
|
| Male | 4 | 2015 | 23409 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2020 | 141 | 0.040 |
Why?
|
| Metagenomics | 1 | 2019 | 46 | 0.040 |
Why?
|
| Kinetics | 1 | 2021 | 695 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2001 | 239 | 0.040 |
Why?
|
| Serum Amyloid A Protein | 1 | 2019 | 14 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 76 | 0.040 |
Why?
|
| Interleukins | 1 | 2019 | 40 | 0.040 |
Why?
|
| Antigens, T-Independent | 1 | 1998 | 1 | 0.040 |
Why?
|
| Polysaccharides, Bacterial | 1 | 1998 | 17 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 203 | 0.040 |
Why?
|
| Antigens | 1 | 1999 | 59 | 0.040 |
Why?
|
| Muramidase | 1 | 1999 | 30 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 1999 | 68 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 1180 | 0.040 |
Why?
|
| Feces | 1 | 1999 | 132 | 0.030 |
Why?
|
| Genotype | 1 | 2021 | 800 | 0.030 |
Why?
|
| Young Adult | 2 | 2019 | 5080 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2021 | 430 | 0.030 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 36 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 140 | 0.030 |
Why?
|
| Adhesins, Bacterial | 1 | 1997 | 21 | 0.030 |
Why?
|
| Sympathomimetics | 1 | 1996 | 8 | 0.030 |
Why?
|
| Neurosecretory Systems | 1 | 1996 | 17 | 0.030 |
Why?
|
| Gynecology | 1 | 2016 | 35 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2016 | 107 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 74 | 0.030 |
Why?
|
| Obstetrics | 1 | 2016 | 43 | 0.030 |
Why?
|
| Cell Division | 3 | 2002 | 311 | 0.030 |
Why?
|
| RNA, Viral | 2 | 2007 | 321 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 182 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2014 | 65 | 0.030 |
Why?
|
| H-2 Antigens | 1 | 2014 | 4 | 0.030 |
Why?
|
| Luciferases | 1 | 2014 | 71 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 241 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2013 | 73 | 0.030 |
Why?
|
| Haplotypes | 1 | 2014 | 197 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 611 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2003 | 1766 | 0.020 |
Why?
|
| Electromagnetic Fields | 1 | 2012 | 10 | 0.020 |
Why?
|
| Pressure | 2 | 2003 | 50 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2012 | 37 | 0.020 |
Why?
|
| HIV Infections | 1 | 2007 | 2586 | 0.020 |
Why?
|
| Ciprofloxacin | 1 | 2012 | 16 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 160 | 0.020 |
Why?
|
| Lipase | 1 | 2011 | 20 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 1612 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2011 | 11 | 0.020 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2011 | 9 | 0.020 |
Why?
|
| Myelin Proteins | 1 | 2011 | 18 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2011 | 83 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2011 | 104 | 0.020 |
Why?
|
| Multigene Family | 1 | 2009 | 105 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2009 | 44 | 0.020 |
Why?
|
| Molecular Imprinting | 1 | 2008 | 2 | 0.020 |
Why?
|
| Spain | 1 | 2008 | 44 | 0.020 |
Why?
|
| Enzymes | 1 | 2008 | 35 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2008 | 165 | 0.020 |
Why?
|
| Antibodies | 1 | 2008 | 144 | 0.020 |
Why?
|
| Normetanephrine | 2 | 1997 | 3 | 0.020 |
Why?
|
| Aptamers, Nucleotide | 1 | 2008 | 51 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 2007 | 20 | 0.020 |
Why?
|
| Shiga Toxin 1 | 2 | 1997 | 3 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 2006 | 36 | 0.020 |
Why?
|
| Nepal | 1 | 2006 | 19 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2006 | 207 | 0.010 |
Why?
|
| Viral Load | 1 | 2007 | 348 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2006 | 190 | 0.010 |
Why?
|
| Ampicillin Resistance | 1 | 2003 | 3 | 0.010 |
Why?
|
| Recombinases | 1 | 2003 | 3 | 0.010 |
Why?
|
| Periodicity | 1 | 2003 | 34 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2003 | 35 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2007 | 549 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2003 | 36 | 0.010 |
Why?
|
| Duodenum | 1 | 2003 | 15 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 80 | 0.010 |
Why?
|
| Equipment Design | 1 | 2003 | 145 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2003 | 97 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 152 | 0.010 |
Why?
|
| Carbon Compounds, Inorganic | 1 | 2002 | 2 | 0.010 |
Why?
|
| Bone Matrix | 1 | 2002 | 8 | 0.010 |
Why?
|
| Prostheses and Implants | 1 | 2002 | 18 | 0.010 |
Why?
|
| Phylogeny | 1 | 2006 | 769 | 0.010 |
Why?
|
| Femur | 1 | 2002 | 47 | 0.010 |
Why?
|
| Cell Count | 1 | 2002 | 145 | 0.010 |
Why?
|
| Bone Development | 1 | 2001 | 28 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 211 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2002 | 168 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 561 | 0.010 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2001 | 12 | 0.010 |
Why?
|
| Complement Activation | 1 | 2001 | 14 | 0.010 |
Why?
|
| Vaccines, Conjugate | 1 | 2001 | 9 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2002 | 112 | 0.010 |
Why?
|
| Elapid Venoms | 1 | 2001 | 16 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2002 | 131 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2001 | 164 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 934 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2001 | 114 | 0.010 |
Why?
|
| Polymers | 1 | 2002 | 155 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2001 | 126 | 0.010 |
Why?
|
| Ficoll | 1 | 1998 | 1 | 0.010 |
Why?
|
| Haptens | 1 | 1998 | 20 | 0.010 |
Why?
|
| Lymphopenia | 1 | 1998 | 17 | 0.010 |
Why?
|
| Neisseria meningitidis | 1 | 1998 | 17 | 0.010 |
Why?
|
| Interferon-alpha | 1 | 1998 | 43 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 1081 | 0.010 |
Why?
|
| Shiga Toxin 2 | 1 | 1997 | 3 | 0.010 |
Why?
|
| Enterotoxins | 1 | 1997 | 33 | 0.010 |
Why?
|
| Culture Media | 1 | 1996 | 96 | 0.010 |
Why?
|
| Cattle | 1 | 1997 | 498 | 0.010 |
Why?
|
| United States | 1 | 2006 | 5205 | 0.010 |
Why?
|